HIG Capital Sells Portfolio Company Accupac to JH Whitney
HIG Capital (HIG) said that it has sold its portfolio company Accupac Inc, (Accupac) to JH Whitney Capital Partners.
Accupac is a leading US provider of outsourced manufacturing and packaging solutions to the world’s largest pharmaceutical and over-the-counter (OTC) personal care product manufacturers.
The company is a specialist in liquid topical and oral care products, including skin creams, toothpaste, moisturizing lotions, mouthwash and other personal care products, many of which require FDA approval. All Accupac manufacturing facilities are FDA registered and cGMP compliant.
Through HIG’s partnership with Accupac’s leadership team, the Company made significant improvements in both operations and sales. During HIG’s investment period, Accupac implemented facility improvements to substantially increase and expand manufacturing capacity.
Furthermore, the company has driven significant growth with new and existing customers given Accupac’s unique ability to manufacture speciality products.
"We are proud of what we accomplished during our partnership with HIG Capital and we are excited to continue Accupac’s growth trajectory with our new partner JH Whitney Capital Partners. We believe that this transaction is the right step for Accupac to continue offering our customers superior quality products," said Paul Alvater, Accupac's CEO.
“Through substantial investment in people and facilities, with a constant focus on customers, Accupac has developed into a market leader. We look forward to seeing Accupac continue its successful growth with JH Whitney Capital Partners,” added John Von Bargen, a managing director of HIG Capital.
2026-10-19
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Brenntag and Momentive Expand Partnership to the Philippines
-
BASF Personal Care Launches Ameriflor Calm
-
Wanhua Chemical’s “Tale of Two Cities”: 850,000 Tonnes Isn’t Capacity—It’s a Declaration of War
-
BASF’s 2025 Report Card—“The Profit Evaporation Act”: Behind the €6.6 Billion EBITDA Lies a Deliberate Strategic Retreat
-
Evonik Inaugurates New Speciality Alumina Plant in Japan, Bolstering Regional Growth Strategy
-
RMB 240 Million! Wanhua Chemical Establishes Another Joint Venture in Binzhou
-
ExxonMobil Shuts Another Singapore Facility: The Global Petrochemical Shake-Up Leaves No Easy Winners
-
Lilly’s Indiana Investment Puts API Capacity at the Center of Obesity Drug Competition
-
After Two Price Hikes in One Week, Dow Has Fully Exposed the Most Sensitive Nerve in Europe’s Polyurethane Market
-
Syngenta’s VIRESTINA Targets Resistant Weeds as Herbicide Innovation Regains Urgency
Recommend Reading
-
BASF’s Price Increase Shows Pharma Excipients Are Still Exposed to Chemical Cost Pressure
-
Brazil’s Pesticide Registration Momentum Keeps Latin America at the Center of Agrochemical Competition
-
Brazil’s Pesticide Registration Momentum Keeps Latin America at the Center of Agrochemical Competition
-
Argentina’s GHS Pesticide Label Rules Raise the Compliance Bar for Agrochemical Exports
-
Argentina’s GHS Pesticide Label Rules Raise the Compliance Bar for Agrochemical Exports
-
This Week's Styrene Market Fluctuates within a Range (11.17-11.21)
-
MTBE Market Prices Rise Significantly in China
-
Business Society’s Market Outlook for MIBK on September 1, 2026: Tending to Be Bearish
-
Phenol Market Rises First then Declines in September, Mainly Consolidating with Fluctuations Afterwards in China
-
This Week's TDI Market Stabilizes (11.17-11.21)